Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-50

hello hello hello

what's going on here.... results a day early. Just goes to show you can't rely on the big shot.

all good. objectives met, as expected. It is when they are not met that you have to worry.

the treatment niave group trial group is what I'm waiting on. this will demonstrate or not the power of BIT225. The very fact that they are able to treat a niave population speaks for itself, so the results will be a make or break. I'm quitely confident in the later because the positive responses in the cART group indicate to me that the efficay will be magnified in the niave group.



Not long now.